Lamotrigine
Product Images NDC 68151-4249

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68151-4249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093068801

Lamotrigine tablets from Carilion Materials Management with imprint '93' on one side and '688' on the other. The tablets are round, white, and the image includes a millimeter scale showing their size.*

FDA Label Image

Figure1.jpg (Figure1)

A Kaplan-Meier survival curve chart showing failure probability over weeks, comparing Placebo and Lamotrigine tablets. The y-axis represents failure probability as a percentage from 0 to 100%, and the x-axis shows time in weeks up to about 90 weeks. The curves indicate failure rates for the two groups, with censored data points marked.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph illustrating failure probability (%) over weeks for Lamotrigine tablets versus placebo. The horizontal axis represents time in weeks, while the vertical axis shows failure probability percentage. Two curves compare treatment groups, with censorship points marked. The placebo curve shows a higher failure probability than the Lamotrigine tablets curve throughout the study period up to about 80 weeks.*

FDA Label Image

Lamotrigine Structural Formula (Image 01)

Chemical structure of lamotrigine showing two chlorine atoms on a benzene ring and an amino-substituted triazine ring linked together.*

FDA Label Image

Depiction Of Lamotrigine Tablets (chewable, Dispersible) (Image 02)

Illustration showing two round tablets of Lamotrigine in two strengths. The 5 mg tablet is white to off-white, debossed with '688' on one side and '93' on the other. The 25 mg tablet is white to off-white, debossed with '132' on one side and '93' on the other.*

FDA Label Image

Label Image (Lbl681514249)

Packaging label for Lamotrigine 5 mg chewable/dispersible tablets. The label shows the manufacturer as Teva, includes lot number 051025, expiration date 07/14, and a barcode with product identifier 00000004249. The label specifies prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.